Carnosine (β-alanyl-
L-histidine), a
dipeptide, is an
endogenous antioxidant widely distributed in excitable tissues like muscles and the brain.
Carnosine is involved in cellular defense mechanisms against oxidative stress, including the inhibition of
amyloid-beta (Aβ) aggregation and the scavenging of reactive species. Microglia play a central role in the pathogenesis of
Alzheimer's disease, promoting
neuroinflammation through the secretion of inflammatory mediators and
free radicals. However, the effects of
carnosine on microglial cells and
neuroinflammation are not well understood. In the present work,
carnosine was tested for its ability to protect BV-2 microglial cells against oligomeric Aβ1-42-induced oxidative stress and
inflammation.
Carnosine prevented cell death in BV-2 cells challenged with Aβ oligomers through multiple mechanisms. Specifically,
carnosine lowered the oxidative stress by decreasing NO and O₂-• intracellular levels as well as the expression of iNOS and Nox
enzymes.
Carnosine also decreased the secretion of pro-inflammatory
cytokines such as IL-1β, simultaneously rescuing
IL-10 levels and increasing the expression and the release of TGF-β1.
Carnosine also prevented Aβ-induced neurodegeneration in mixed neuronal cultures challenged with Aβ oligomers, and these
neuroprotective effects were completely abolished by
SB431542, a selective inhibitor of the type-1 TGF-β receptor. Our data suggest a multimodal mechanism of action of
carnosine underlying its protective effects on microglial cells against Aβ toxicity with a key role of TGF-β1 in mediating these protective effects.